Pharmacology treatment principles in PCOS combined with obesity.

Abstract

Rates of weight gain and prevalence of excess weight are increasing in the world and are further increased in female with polycystic ovary syndrome (PCOS).The comorbidity of excess weight and PCOS, negatively effects reproductive, metabolic and physiological health. This both pathologies are usually combined with hyperandrogenism and hyperandrogenaemia. All this need prevention and treatment. Insulin resistance affects 75% of lean women and 95% of those with a BMI more 25kg/m2 with PCOS and is further exacerbated by excess weight. The aim of the study. To evaluate effect of usage of liraglutide in female with PCOS combined with obesity.